nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—CYP1A1—chronic kidney failure	0.249	0.367	CbGaD
Erlotinib—CYP3A4—chronic kidney failure	0.159	0.234	CbGaD
Erlotinib—ALB—chronic kidney failure	0.139	0.204	CbGaD
Erlotinib—ABCB1—chronic kidney failure	0.132	0.195	CbGaD
Erlotinib—STK10—renal artery—chronic kidney failure	0.0138	0.129	CbGeAlD
Erlotinib—UGT1A1—urine—chronic kidney failure	0.00365	0.0342	CbGeAlD
Erlotinib—FLT3—blood plasma—chronic kidney failure	0.00302	0.0283	CbGeAlD
Erlotinib—HIPK4—gonad—chronic kidney failure	0.00203	0.0191	CbGeAlD
Erlotinib—STK10—blood plasma—chronic kidney failure	0.00202	0.0189	CbGeAlD
Erlotinib—UGT1A1—blood plasma—chronic kidney failure	0.00191	0.0179	CbGeAlD
Erlotinib—NR1I2—digestive system—chronic kidney failure	0.00184	0.0173	CbGeAlD
Erlotinib—AURKC—gonad—chronic kidney failure	0.00174	0.0163	CbGeAlD
Erlotinib—Vandetanib—VEGFA—chronic kidney failure	0.00173	0.304	CrCbGaD
Erlotinib—TNK1—urethra—chronic kidney failure	0.00162	0.0152	CbGeAlD
Erlotinib—CYP1A2—urine—chronic kidney failure	0.00162	0.0152	CbGeAlD
Erlotinib—EPHA6—gonad—chronic kidney failure	0.00161	0.0151	CbGeAlD
Erlotinib—JAK3—digestive system—chronic kidney failure	0.00147	0.0138	CbGeAlD
Erlotinib—PIP4K2C—nephron tubule—chronic kidney failure	0.00141	0.0132	CbGeAlD
Erlotinib—JAK3—blood—chronic kidney failure	0.0014	0.0131	CbGeAlD
Erlotinib—FLT3—cardiovascular system—chronic kidney failure	0.0014	0.0131	CbGeAlD
Erlotinib—TNK1—blood—chronic kidney failure	0.00129	0.0121	CbGeAlD
Erlotinib—FLT3—gonad—chronic kidney failure	0.00127	0.0119	CbGeAlD
Erlotinib—PIP4K2C—urethra—chronic kidney failure	0.00126	0.0118	CbGeAlD
Erlotinib—PIP4K2C—cortex of kidney—chronic kidney failure	0.0012	0.0113	CbGeAlD
Erlotinib—ULK3—urethra—chronic kidney failure	0.0012	0.0112	CbGeAlD
Erlotinib—SLK—nephron tubule—chronic kidney failure	0.0012	0.0112	CbGeAlD
Erlotinib—CYP3A4—urine—chronic kidney failure	0.00117	0.011	CbGeAlD
Erlotinib—CYP2D6—urine—chronic kidney failure	0.00115	0.0108	CbGeAlD
Erlotinib—ULK3—cortex of kidney—chronic kidney failure	0.00115	0.0108	CbGeAlD
Erlotinib—PIP4K2C—gonad—chronic kidney failure	0.00115	0.0107	CbGeAlD
Erlotinib—MKNK1—cardiovascular system—chronic kidney failure	0.00113	0.0106	CbGeAlD
Erlotinib—MKNK1—urethra—chronic kidney failure	0.00113	0.0106	CbGeAlD
Erlotinib—FLT3—blood—chronic kidney failure	0.00111	0.0104	CbGeAlD
Erlotinib—ULK3—gonad—chronic kidney failure	0.00109	0.0103	CbGeAlD
Erlotinib—MKNK1—cortex of kidney—chronic kidney failure	0.00108	0.0101	CbGeAlD
Erlotinib—SLK—urethra—chronic kidney failure	0.00107	0.01	CbGeAlD
Erlotinib—ABL2—blood—chronic kidney failure	0.00106	0.0099	CbGeAlD
Erlotinib—MKNK1—gonad—chronic kidney failure	0.00103	0.00966	CbGeAlD
Erlotinib—SLK—cortex of kidney—chronic kidney failure	0.00102	0.00961	CbGeAlD
Erlotinib—ULK3—digestive system—chronic kidney failure	0.001	0.00939	CbGeAlD
Erlotinib—PIP4K2C—blood—chronic kidney failure	0.000999	0.00937	CbGeAlD
Erlotinib—ULK3—blood—chronic kidney failure	0.000954	0.00894	CbGeAlD
Erlotinib—STK10—renal system—chronic kidney failure	0.000946	0.00887	CbGeAlD
Erlotinib—MKNK1—digestive system—chronic kidney failure	0.000942	0.00884	CbGeAlD
Erlotinib—STK10—cardiovascular system—chronic kidney failure	0.000935	0.00877	CbGeAlD
Erlotinib—STK10—kidney—chronic kidney failure	0.000914	0.00858	CbGeAlD
Erlotinib—CYP2C8—blood plasma—chronic kidney failure	0.000901	0.00845	CbGeAlD
Erlotinib—MKNK1—blood—chronic kidney failure	0.000898	0.00842	CbGeAlD
Erlotinib—UGT1A1—renal system—chronic kidney failure	0.000893	0.00838	CbGeAlD
Erlotinib—UGT1A1—kidney—chronic kidney failure	0.000864	0.0081	CbGeAlD
Erlotinib—SLK—blood—chronic kidney failure	0.00085	0.00797	CbGeAlD
Erlotinib—STK10—gonad—chronic kidney failure	0.000848	0.00796	CbGeAlD
Erlotinib—CYP1A2—blood plasma—chronic kidney failure	0.000844	0.00791	CbGeAlD
Erlotinib—MAP2K5—cardiovascular system—chronic kidney failure	0.000835	0.00783	CbGeAlD
Erlotinib—MAP2K5—urethra—chronic kidney failure	0.00083	0.00778	CbGeAlD
Erlotinib—CYP3A5—blood plasma—chronic kidney failure	0.000814	0.00763	CbGeAlD
Erlotinib—MAP2K5—cortex of kidney—chronic kidney failure	0.000795	0.00746	CbGeAlD
Erlotinib—Gefitinib—CYP2C19—chronic kidney failure	0.000795	0.14	CrCbGaD
Erlotinib—Gefitinib—CYP1A1—chronic kidney failure	0.000792	0.14	CrCbGaD
Erlotinib—STK10—digestive system—chronic kidney failure	0.000776	0.00728	CbGeAlD
Erlotinib—STK10—blood—chronic kidney failure	0.000739	0.00693	CbGeAlD
Erlotinib—UGT1A1—digestive system—chronic kidney failure	0.000733	0.00687	CbGeAlD
Erlotinib—ABL1—nephron tubule—chronic kidney failure	0.000717	0.00672	CbGeAlD
Erlotinib—UGT1A1—blood—chronic kidney failure	0.000698	0.00655	CbGeAlD
Erlotinib—MAP2K5—blood—chronic kidney failure	0.00066	0.00619	CbGeAlD
Erlotinib—SLCO2B1—renal system—chronic kidney failure	0.000657	0.00616	CbGeAlD
Erlotinib—ABL1—renal system—chronic kidney failure	0.000652	0.00611	CbGeAlD
Erlotinib—ABL1—cardiovascular system—chronic kidney failure	0.000644	0.00604	CbGeAlD
Erlotinib—ABL1—urethra—chronic kidney failure	0.00064	0.006	CbGeAlD
Erlotinib—SLCO2B1—kidney—chronic kidney failure	0.000635	0.00596	CbGeAlD
Erlotinib—ABL1—kidney—chronic kidney failure	0.00063	0.00591	CbGeAlD
Erlotinib—ABL1—cortex of kidney—chronic kidney failure	0.000614	0.00575	CbGeAlD
Erlotinib—CYP3A4—blood plasma—chronic kidney failure	0.000611	0.00573	CbGeAlD
Erlotinib—CYP1B1—nephron tubule—chronic kidney failure	0.000607	0.00569	CbGeAlD
Erlotinib—CYP2D6—blood plasma—chronic kidney failure	0.000601	0.00564	CbGeAlD
Erlotinib—ABL1—gonad—chronic kidney failure	0.000584	0.00548	CbGeAlD
Erlotinib—CYP1B1—renal system—chronic kidney failure	0.000552	0.00518	CbGeAlD
Erlotinib—CYP1B1—cardiovascular system—chronic kidney failure	0.000545	0.00511	CbGeAlD
Erlotinib—SLCO2B1—digestive system—chronic kidney failure	0.000539	0.00506	CbGeAlD
Erlotinib—ORM1—blood—chronic kidney failure	0.000536	0.00503	CbGeAlD
Erlotinib—ABL1—digestive system—chronic kidney failure	0.000534	0.00501	CbGeAlD
Erlotinib—CYP1B1—kidney—chronic kidney failure	0.000534	0.005	CbGeAlD
Erlotinib—Vandetanib—CYP3A4—chronic kidney failure	0.000532	0.0937	CrCbGaD
Erlotinib—CYP1B1—cortex of kidney—chronic kidney failure	0.00052	0.00487	CbGeAlD
Erlotinib—ABL1—blood—chronic kidney failure	0.000509	0.00478	CbGeAlD
Erlotinib—Gefitinib—CYP3A4—chronic kidney failure	0.000506	0.0891	CrCbGaD
Erlotinib—CYP1B1—gonad—chronic kidney failure	0.000495	0.00464	CbGeAlD
Erlotinib—Vandetanib—ALB—chronic kidney failure	0.000464	0.0818	CrCbGaD
Erlotinib—CYP1B1—digestive system—chronic kidney failure	0.000453	0.00425	CbGeAlD
Erlotinib—ABCG2—nephron tubule—chronic kidney failure	0.000452	0.00424	CbGeAlD
Erlotinib—Gefitinib—ALB—chronic kidney failure	0.000441	0.0777	CrCbGaD
Erlotinib—ABCB1—blood plasma—chronic kidney failure	0.000432	0.00405	CbGeAlD
Erlotinib—CYP1B1—blood—chronic kidney failure	0.000431	0.00404	CbGeAlD
Erlotinib—CYP2C8—renal system—chronic kidney failure	0.000423	0.00396	CbGeAlD
Erlotinib—Gefitinib—ABCB1—chronic kidney failure	0.000421	0.0741	CrCbGaD
Erlotinib—CYP3A5—nephron tubule—chronic kidney failure	0.00042	0.00394	CbGeAlD
Erlotinib—CYP2C8—kidney—chronic kidney failure	0.000409	0.00383	CbGeAlD
Erlotinib—ABCG2—urethra—chronic kidney failure	0.000404	0.00379	CbGeAlD
Erlotinib—CYP1A2—renal system—chronic kidney failure	0.000395	0.00371	CbGeAlD
Erlotinib—CYP1A1—renal system—chronic kidney failure	0.00039	0.00366	CbGeAlD
Erlotinib—CYP1A1—urethra—chronic kidney failure	0.000383	0.00359	CbGeAlD
Erlotinib—CYP3A5—renal system—chronic kidney failure	0.000381	0.00358	CbGeAlD
Erlotinib—CYP1A1—kidney—chronic kidney failure	0.000377	0.00354	CbGeAlD
Erlotinib—CYP3A5—kidney—chronic kidney failure	0.000369	0.00346	CbGeAlD
Erlotinib—CYP3A5—cortex of kidney—chronic kidney failure	0.000359	0.00337	CbGeAlD
Erlotinib—CYP2C8—blood—chronic kidney failure	0.00033	0.0031	CbGeAlD
Erlotinib—CYP1A2—digestive system—chronic kidney failure	0.000324	0.00304	CbGeAlD
Erlotinib—ABCG2—blood—chronic kidney failure	0.000321	0.00301	CbGeAlD
Erlotinib—CYP1A1—digestive system—chronic kidney failure	0.00032	0.003	CbGeAlD
Erlotinib—CYP3A5—digestive system—chronic kidney failure	0.000313	0.00293	CbGeAlD
Erlotinib—CYP1A2—blood—chronic kidney failure	0.000309	0.0029	CbGeAlD
Erlotinib—CYP1A1—blood—chronic kidney failure	0.000305	0.00286	CbGeAlD
Erlotinib—CYP3A5—blood—chronic kidney failure	0.000298	0.0028	CbGeAlD
Erlotinib—CYP3A4—renal system—chronic kidney failure	0.000286	0.00268	CbGeAlD
Erlotinib—CYP2D6—renal system—chronic kidney failure	0.000282	0.00264	CbGeAlD
Erlotinib—CYP3A4—kidney—chronic kidney failure	0.000277	0.0026	CbGeAlD
Erlotinib—CYP2D6—kidney—chronic kidney failure	0.000272	0.00255	CbGeAlD
Erlotinib—CYP3A4—digestive system—chronic kidney failure	0.000235	0.0022	CbGeAlD
Erlotinib—CYP2D6—digestive system—chronic kidney failure	0.000231	0.00217	CbGeAlD
Erlotinib—CYP3A4—blood—chronic kidney failure	0.000224	0.0021	CbGeAlD
Erlotinib—ABCB1—nephron tubule—chronic kidney failure	0.000223	0.00209	CbGeAlD
Erlotinib—CYP2D6—blood—chronic kidney failure	0.00022	0.00206	CbGeAlD
Erlotinib—ABCB1—renal system—chronic kidney failure	0.000203	0.0019	CbGeAlD
Erlotinib—ABCB1—cardiovascular system—chronic kidney failure	0.0002	0.00188	CbGeAlD
Erlotinib—ABCB1—urethra—chronic kidney failure	0.000199	0.00187	CbGeAlD
Erlotinib—ABCB1—kidney—chronic kidney failure	0.000196	0.00184	CbGeAlD
Erlotinib—ABCB1—cortex of kidney—chronic kidney failure	0.000191	0.00179	CbGeAlD
Erlotinib—ABCB1—gonad—chronic kidney failure	0.000182	0.0017	CbGeAlD
Erlotinib—ABCB1—digestive system—chronic kidney failure	0.000166	0.00156	CbGeAlD
Erlotinib—ABCB1—blood—chronic kidney failure	0.000158	0.00148	CbGeAlD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	8.62e-06	4.12e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—SREBF1—chronic kidney failure	8.59e-06	4.11e-05	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL6—chronic kidney failure	8.56e-06	4.09e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MTHFR—chronic kidney failure	8.55e-06	4.08e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RELA—chronic kidney failure	8.52e-06	4.07e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—IL6—chronic kidney failure	8.52e-06	4.07e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PRKD1—chronic kidney failure	8.5e-06	4.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP2B6—chronic kidney failure	8.5e-06	4.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PRKAG2—chronic kidney failure	8.5e-06	4.06e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC22A2—chronic kidney failure	8.42e-06	4.02e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PPARA—chronic kidney failure	8.38e-06	4.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AVP—chronic kidney failure	8.38e-06	4.01e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	8.37e-06	4e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—HMGCR—chronic kidney failure	8.36e-06	3.99e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CYP1A1—chronic kidney failure	8.34e-06	3.99e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—RELA—chronic kidney failure	8.28e-06	3.95e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IRS1—chronic kidney failure	8.26e-06	3.95e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS3—chronic kidney failure	8.25e-06	3.94e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—FASN—chronic kidney failure	8.18e-06	3.91e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SCARB1—chronic kidney failure	8.11e-06	3.88e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	8.08e-06	3.86e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SCARB1—chronic kidney failure	8.07e-06	3.86e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS1—chronic kidney failure	8.03e-06	3.84e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CYP3A4—chronic kidney failure	8.02e-06	3.83e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—VEGFA—chronic kidney failure	8e-06	3.82e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS1—chronic kidney failure	7.99e-06	3.82e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—EDN1—chronic kidney failure	7.97e-06	3.81e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SREBF2—chronic kidney failure	7.96e-06	3.8e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL5—chronic kidney failure	7.91e-06	3.78e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	7.9e-06	3.78e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—KRAS—chronic kidney failure	7.9e-06	3.78e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ABCA1—chronic kidney failure	7.88e-06	3.77e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SREBF1—chronic kidney failure	7.88e-06	3.76e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CPT1A—chronic kidney failure	7.85e-06	3.75e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SREBF1—chronic kidney failure	7.83e-06	3.74e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCG1—chronic kidney failure	7.83e-06	3.74e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MTHFR—chronic kidney failure	7.78e-06	3.72e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LPL—chronic kidney failure	7.73e-06	3.7e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GCKR—chronic kidney failure	7.69e-06	3.67e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCC3—chronic kidney failure	7.69e-06	3.67e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—HMGCR—chronic kidney failure	7.66e-06	3.66e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PIP5K1B—chronic kidney failure	7.66e-06	3.66e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LIPC—chronic kidney failure	7.65e-06	3.66e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP2C19—chronic kidney failure	7.65e-06	3.66e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPARA—chronic kidney failure	7.63e-06	3.65e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—HMGCR—chronic kidney failure	7.62e-06	3.64e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—KRAS—chronic kidney failure	7.59e-06	3.63e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CYP3A4—chronic kidney failure	7.58e-06	3.62e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	7.54e-06	3.6e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LPIN1—chronic kidney failure	7.52e-06	3.6e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—chronic kidney failure	7.52e-06	3.59e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ARG2—chronic kidney failure	7.51e-06	3.59e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—FASN—chronic kidney failure	7.5e-06	3.58e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—chronic kidney failure	7.48e-06	3.58e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—FASN—chronic kidney failure	7.46e-06	3.56e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ABCA1—chronic kidney failure	7.45e-06	3.56e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CPT1A—chronic kidney failure	7.4e-06	3.54e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	7.39e-06	3.53e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LRP2—chronic kidney failure	7.37e-06	3.52e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP2C18—chronic kidney failure	7.37e-06	3.52e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LCAT—chronic kidney failure	7.36e-06	3.52e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—chronic kidney failure	7.34e-06	3.51e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—chronic kidney failure	7.34e-06	3.51e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—POMC—chronic kidney failure	7.33e-06	3.5e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NGF—chronic kidney failure	7.33e-06	3.5e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—chronic kidney failure	7.28e-06	3.48e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—SERPINE1—chronic kidney failure	7.26e-06	3.47e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LIPC—chronic kidney failure	7.21e-06	3.45e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	7.21e-06	3.45e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NFKB1—chronic kidney failure	7.18e-06	3.43e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR5—chronic kidney failure	7.13e-06	3.41e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—RELA—chronic kidney failure	7.07e-06	3.38e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SCARB1—chronic kidney failure	7.07e-06	3.38e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS1—chronic kidney failure	7e-06	3.34e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NFKB1—chronic kidney failure	6.98e-06	3.34e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	6.95e-06	3.32e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS3—chronic kidney failure	6.94e-06	3.31e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	6.91e-06	3.3e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP3A4—chronic kidney failure	6.91e-06	3.3e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	6.87e-06	3.28e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SREBF1—chronic kidney failure	6.86e-06	3.28e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—POMC—chronic kidney failure	6.83e-06	3.27e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCA1—chronic kidney failure	6.83e-06	3.26e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—KRAS—chronic kidney failure	6.8e-06	3.25e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCA1—chronic kidney failure	6.79e-06	3.25e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DDC—chronic kidney failure	6.76e-06	3.23e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ALB—chronic kidney failure	6.68e-06	3.19e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—HMGCR—chronic kidney failure	6.68e-06	3.19e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CAT—chronic kidney failure	6.67e-06	3.19e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SCARB1—chronic kidney failure	6.66e-06	3.18e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS1—chronic kidney failure	6.59e-06	3.15e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	6.56e-06	3.14e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PRKD1—chronic kidney failure	6.56e-06	3.14e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	6.56e-06	3.14e-05	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	6.54e-06	3.13e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—FASN—chronic kidney failure	6.53e-06	3.12e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—VEGFA—chronic kidney failure	6.52e-06	3.12e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ABCB1—chronic kidney failure	6.49e-06	3.1e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SREBF1—chronic kidney failure	6.47e-06	3.09e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—chronic kidney failure	6.43e-06	3.07e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—chronic kidney failure	6.39e-06	3.06e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NOS3—chronic kidney failure	6.39e-06	3.05e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—chronic kidney failure	6.34e-06	3.03e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAT—chronic kidney failure	6.31e-06	3.01e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—HMGCR—chronic kidney failure	6.29e-06	3.01e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CPT1A—chronic kidney failure	6.27e-06	3e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ALB—chronic kidney failure	6.23e-06	2.98e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—POMC—chronic kidney failure	6.22e-06	2.97e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—LPL—chronic kidney failure	6.19e-06	2.96e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—FASN—chronic kidney failure	6.16e-06	2.94e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SREBF2—chronic kidney failure	6.14e-06	2.94e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ABCB1—chronic kidney failure	6.13e-06	2.93e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—F2—chronic kidney failure	6.11e-06	2.92e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP2C19—chronic kidney failure	6.11e-06	2.92e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LIPC—chronic kidney failure	6.11e-06	2.92e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP3A4—chronic kidney failure	6.05e-06	2.89e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	6.03e-06	2.88e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—chronic kidney failure	5.99e-06	2.86e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CYP1A1—chronic kidney failure	5.98e-06	2.86e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NFKB1—chronic kidney failure	5.96e-06	2.85e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NOS3—chronic kidney failure	5.96e-06	2.85e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ABCA1—chronic kidney failure	5.95e-06	2.84e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—VEGFA—chronic kidney failure	5.95e-06	2.84e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GCKR—chronic kidney failure	5.93e-06	2.84e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCC3—chronic kidney failure	5.93e-06	2.84e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—chronic kidney failure	5.85e-06	2.79e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—LPL—chronic kidney failure	5.85e-06	2.79e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LPIN1—chronic kidney failure	5.81e-06	2.78e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IRS1—chronic kidney failure	5.78e-06	2.76e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAT—chronic kidney failure	5.78e-06	2.76e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAT—chronic kidney failure	5.75e-06	2.75e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	5.7e-06	2.73e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	5.69e-06	2.72e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LRP2—chronic kidney failure	5.69e-06	2.72e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ALB—chronic kidney failure	5.67e-06	2.71e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SCARB1—chronic kidney failure	5.64e-06	2.7e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCB1—chronic kidney failure	5.62e-06	2.69e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCA1—chronic kidney failure	5.61e-06	2.68e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCB1—chronic kidney failure	5.59e-06	2.67e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS1—chronic kidney failure	5.59e-06	2.67e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MTHFR—chronic kidney failure	5.57e-06	2.66e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—POMC—chronic kidney failure	5.57e-06	2.66e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—KRAS—chronic kidney failure	5.54e-06	2.65e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—chronic kidney failure	5.53e-06	2.64e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	5.49e-06	2.63e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SREBF1—chronic kidney failure	5.48e-06	2.62e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARA—chronic kidney failure	5.47e-06	2.61e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—chronic kidney failure	5.46e-06	2.61e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—chronic kidney failure	5.45e-06	2.61e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—chronic kidney failure	5.45e-06	2.6e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NOS3—chronic kidney failure	5.42e-06	2.59e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—KRAS—chronic kidney failure	5.38e-06	2.57e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—LPL—chronic kidney failure	5.36e-06	2.56e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IGF1—chronic kidney failure	5.36e-06	2.56e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—HMGCR—chronic kidney failure	5.33e-06	2.55e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—LPL—chronic kidney failure	5.33e-06	2.55e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MTHFR—chronic kidney failure	5.26e-06	2.52e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—FASN—chronic kidney failure	5.21e-06	2.49e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	5.18e-06	2.47e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARA—chronic kidney failure	5.16e-06	2.47e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP1A1—chronic kidney failure	5.15e-06	2.46e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SERPINE1—chronic kidney failure	5.09e-06	2.43e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—KRAS—chronic kidney failure	5.05e-06	2.42e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAT—chronic kidney failure	5.04e-06	2.41e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—KRAS—chronic kidney failure	5.04e-06	2.41e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—chronic kidney failure	4.96e-06	2.37e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—chronic kidney failure	4.86e-06	2.32e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CPT1A—chronic kidney failure	4.84e-06	2.31e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP3A4—chronic kidney failure	4.83e-06	2.31e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MTHFR—chronic kidney failure	4.83e-06	2.31e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	4.81e-06	2.3e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MTHFR—chronic kidney failure	4.8e-06	2.29e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCA1—chronic kidney failure	4.75e-06	2.27e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAT—chronic kidney failure	4.75e-06	2.27e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARA—chronic kidney failure	4.73e-06	2.26e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LIPC—chronic kidney failure	4.71e-06	2.25e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	4.71e-06	2.25e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARA—chronic kidney failure	4.71e-06	2.25e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—LPL—chronic kidney failure	4.67e-06	2.23e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCB1—chronic kidney failure	4.62e-06	2.21e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—KRAS—chronic kidney failure	4.6e-06	2.2e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—chronic kidney failure	4.59e-06	2.19e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RELA—chronic kidney failure	4.57e-06	2.18e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—chronic kidney failure	4.51e-06	2.16e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP1A1—chronic kidney failure	4.51e-06	2.15e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—chronic kidney failure	4.46e-06	2.13e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—LPL—chronic kidney failure	4.4e-06	2.1e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—chronic kidney failure	4.38e-06	2.09e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SCARB1—chronic kidney failure	4.36e-06	2.08e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS1—chronic kidney failure	4.31e-06	2.06e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	4.25e-06	2.03e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—KRAS—chronic kidney failure	4.25e-06	2.03e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SREBF1—chronic kidney failure	4.23e-06	2.02e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—chronic kidney failure	4.21e-06	2.01e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MTHFR—chronic kidney failure	4.2e-06	2.01e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARA—chronic kidney failure	4.12e-06	1.97e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—HMGCR—chronic kidney failure	4.11e-06	1.97e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—chronic kidney failure	4.1e-06	1.96e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—chronic kidney failure	4.06e-06	1.94e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—FASN—chronic kidney failure	4.02e-06	1.92e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAT—chronic kidney failure	4.02e-06	1.92e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MTHFR—chronic kidney failure	3.96e-06	1.89e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCB1—chronic kidney failure	3.91e-06	1.87e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARA—chronic kidney failure	3.89e-06	1.86e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—chronic kidney failure	3.89e-06	1.86e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—chronic kidney failure	3.86e-06	1.84e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NFKB1—chronic kidney failure	3.86e-06	1.84e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—chronic kidney failure	3.84e-06	1.83e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—chronic kidney failure	3.84e-06	1.83e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—chronic kidney failure	3.74e-06	1.79e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LPL—chronic kidney failure	3.73e-06	1.78e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—chronic kidney failure	3.67e-06	1.75e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCA1—chronic kidney failure	3.67e-06	1.75e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP1A1—chronic kidney failure	3.6e-06	1.72e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—chronic kidney failure	3.55e-06	1.7e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—chronic kidney failure	3.52e-06	1.68e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VEGFA—chronic kidney failure	3.5e-06	1.67e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—chronic kidney failure	3.46e-06	1.65e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—chronic kidney failure	3.37e-06	1.61e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—chronic kidney failure	3.36e-06	1.61e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—chronic kidney failure	3.36e-06	1.6e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MTHFR—chronic kidney failure	3.36e-06	1.6e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—chronic kidney failure	3.35e-06	1.6e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARA—chronic kidney failure	3.29e-06	1.57e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—chronic kidney failure	3.21e-06	1.53e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—chronic kidney failure	3.17e-06	1.51e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAT—chronic kidney failure	3.1e-06	1.48e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—chronic kidney failure	3.08e-06	1.47e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—chronic kidney failure	3.07e-06	1.46e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—chronic kidney failure	3.06e-06	1.46e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCB1—chronic kidney failure	3.02e-06	1.44e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—KRAS—chronic kidney failure	2.97e-06	1.42e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—chronic kidney failure	2.93e-06	1.4e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—chronic kidney failure	2.89e-06	1.38e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LPL—chronic kidney failure	2.88e-06	1.37e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	2.78e-06	1.33e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—chronic kidney failure	2.76e-06	1.32e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—chronic kidney failure	2.68e-06	1.28e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—chronic kidney failure	2.68e-06	1.28e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MTHFR—chronic kidney failure	2.59e-06	1.24e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARA—chronic kidney failure	2.54e-06	1.21e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—chronic kidney failure	2.53e-06	1.21e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—chronic kidney failure	2.45e-06	1.17e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—chronic kidney failure	2.42e-06	1.16e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—chronic kidney failure	2.34e-06	1.12e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—chronic kidney failure	2.14e-06	1.02e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—chronic kidney failure	2.07e-06	9.9e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—chronic kidney failure	1.89e-06	9.02e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—chronic kidney failure	1.81e-06	8.63e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—chronic kidney failure	1.65e-06	7.9e-06	CbGpPWpGaD
